XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 220 filers reported holding XENON PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,865,359 | -4.3% | 47,842 | +5.6% | 0.00% | 0.0% |
| Q1 2024 | $1,949,562 | +5.1% | 45,286 | -16.6% | 0.00% | -40.0% |
| Q3 2023 | $1,854,376 | +60.7% | 54,285 | +81.1% | 0.01% | +25.0% |
| Q2 2023 | $1,153,730 | +123.0% | 29,967 | +107.3% | 0.00% | +100.0% |
| Q1 2023 | $517,273 | -82.7% | 14,453 | -80.9% | 0.00% | -87.5% |
| Q4 2022 | $2,987,177 | +139.9% | 75,759 | +119.7% | 0.02% | +128.6% |
| Q3 2022 | $1,245,000 | +178.5% | 34,483 | +141.1% | 0.01% | +133.3% |
| Q4 2021 | $447,000 | – | 14,304 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,516,851 | $44,101,000 | 2.72% |
| Parkman Healthcare Partners LLC | 590,267 | $7,402,000 | 2.08% |
| ACUTA CAPITAL PARTNERS, LLC | 517,500 | $6,489,000 | 1.88% |
| Soleus Capital Management, L.P. | 250,897 | $3,146,000 | 1.79% |
| DAFNA Capital Management LLC | 346,535 | $4,346,000 | 1.25% |
| KNOTT DAVID M | 169,000 | $2,119,000 | 1.16% |
| Ghost Tree Capital, LLC | 325,000 | $4,076,000 | 1.08% |
| Avoro Capital Advisors LLC | 2,800,000 | $35,112,000 | 0.69% |
| NEA Management Company, LLC | 992,107 | $12,441,000 | 0.50% |
| Orbimed Advisors | 2,497,917 | $31,324,000 | 0.44% |